Video

DDNA19: Cardiac Complications in Liver Disease Patients


 

AT DIGESTIVE DISEASES: NEW ADVANCES

Vidyard Video

Dr. Marc Klapholz of Rutgers University, Newark, N.J., explains the latest developments in portopulmonary arterial hypertension, hepatopulmonary syndrome, and cirrhotic cardiomyopathy, as well as the emerging field and association between non-alcoholic fatty liver disease and cardiovascular disease.

Recommended Reading

FDA approves cabozantinib for previously treated HCC
MDedge Internal Medicine
Host stress response may be a factor in early-stage HCV clearance
MDedge Internal Medicine
Perceptions of liver transplantation for ALD are evolving
MDedge Internal Medicine
AGA Clinical Practice Update: Surgical risk assessment and perioperative management in cirrhosis
MDedge Internal Medicine
Caring for aging HIV-infected patients requires close attention to unrelated diseases
MDedge Internal Medicine
Novel capsid assembly modulator shows promise in HBV
MDedge Internal Medicine
Possible biomarkers found for progression to liver cancer in chronic HCV infection
MDedge Internal Medicine
Developing an HCV vaccine faces significant challenges
MDedge Internal Medicine
Women survive more often than men do when hospitalized with cirrhosis
MDedge Internal Medicine
One-time, universal hepatitis C testing cost effective, researchers say
MDedge Internal Medicine